Donor Age More Than 20 Years Greater Than Recipient Age Is Associated With Worse 5-Year Survival in Young Adult Heart Transplantation

被引:0
|
作者
Lo, Bryan [1 ]
Nordan, Taylor [1 ]
Sparks, Aaron [1 ]
Lee, Lawrence [1 ]
Zhan, Yong [1 ]
Chen, Frederick Y. [1 ]
Couper, Gregory S. [1 ]
Kawabori, Masashi [1 ]
机构
[1] Cardiovasc Ctr, Tufts Med Ctr, Div Cardiac Surg, 800 Washington St, South Bldg, 6th floor, Boston, MA 02111 USA
关键词
heart transplantation; survival analysis; young adult recipient; recipient donor age difference;
D O I
10.1097/MAT.0000000000002203
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Prior studies indicate donor age-recipient age (DA-RA) difference may be of prognostic value in adolescents, although not adults. We aim to analyze the relationship between DA-RA difference and long-term survival of young adult heart transplantation (HTx) recipients. First-time, single-organ HTx recipients aged 18-30 who underwent HTx between 2010 and 2020 were analyzed from the United Network for Organ Sharing (UNOS) registry. Four cohorts were created based on DA-RA difference. The primary outcome was 5 year post-HTx survival. Secondary outcome was post-HTx complications. One thousand eight hundred three donor-recipient pairs were divided into four groups: DA-RA < 0, 0 <= DA-RA < 10, 10 <= DA-RA < 20, and DA-RA >= 20 with 682 (37.8%), 651 (36.1%), 356 (19.7%), 114 (6.3%) pairs in each cohort, respectively. The estimated 5 year survival of the DA-RA >= 20 cohort was 66.5% compared to the other three groups at similar to 75%. After adjustment, DA-RA >= 20 was independently associated with worse survival compared to DA-RA < 0 (adjusted hazard ratio [HR] = 1.55; 95% confidence interval [CI] = 1.06-2.27; log-rank p = 0.008). There was no significant difference in complication incidence across cohorts. Among young adults, accepting a donor heart more than 20 years older than the recipient was associated with worse 5 year survival. We did not detect a significant difference up to 20 years. This information may help guide appropriate donor selection in the young adult population.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 41 条
  • [31] Survival and Neurocognitive Outcomes After Cardiac Extracorporeal Life Support in Children Less Than 5 Years of Age A Ten-Year Cohort
    Ryerson, Lindsay M.
    Guerra, Gonzalo Garcia
    Joffe, Ari R.
    Robertson, Charlene M. T.
    Alton, Gwen Y.
    Dinu, Irina A.
    Granoski, Don
    Rebeyka, Ivan M.
    Ross, David B.
    Lequier, Laurance
    CIRCULATION-HEART FAILURE, 2015, 8 (02) : 312 - +
  • [32] Living-donor liver transplantation using donors older than 50 years of age: Recipient criteria and donor risk: A multicenter study of Japanese Society of Hepato-Biliary-Pancreatic Surgery
    Toshima, Takeo
    Yoshizumi, Tomoharu
    Takada, Yasutsugu
    Ito, Takashi
    Shinoda, Masahiro
    Takahara, Takeshi
    Ishido, Keinosuke
    Takamura, Hiroyuki
    Taketomi, Akinobu
    Chiba, Naokazu
    Nakamura, Masafumi
    Shirabe, Ken
    Endo, Itaru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2025,
  • [33] Pre-transplant disease burden rather than age or donor type was associated with survival of hematopoietic cell transplantation for elderly patients with acute myeloid leukemia
    Ma, Rui
    Liao, Yi
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Mo, Xiao-Dong
    Lv, Meng
    Zhang, Yuan-Yuan
    Yan, Chen-Hua
    Chen, Yu-Hong
    Chen, Yao
    Wang, Jing-Zhi
    Wang, Feng-Rong
    Han, Ting-Ting
    Wang, Zhi-Dong
    Han, Wei
    Chen, Huan
    He, Yun
    Xu, Zheng-Li
    Zheng, Feng-Mei
    Fu, Hai-Xia
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Sun, Yu-Qian
    BONE MARROW TRANSPLANTATION, 2025, 60 (01) : 107 - 109
  • [34] Time-dependent risk factors influencing the long-term outcome in living renal allografts - Donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation
    Toma, H
    Tanabe, K
    Tokumoto, T
    Shimizu, T
    Shimmura, H
    TRANSPLANTATION, 2001, 72 (05) : 940 - 947
  • [35] GREATER VARIABILITY IN DIASTOLIC-THAN SYSTOLIC AMBULATORY BLOOD PRESSURE IS ASSOCIATED WITH HIGH RISK FOR CARDIOVASCULAR MORTALITY WITHIN 5 YEARS IN SUBJECTS OVER 50 YEARS OF AGE
    Gavish, B.
    Bilo, G.
    Dolan, E.
    O'brien, E.
    Parati, G.
    JOURNAL OF HYPERTENSION, 2019, 37 : E292 - E292
  • [36] 5-YEAR FOLLOW-UP OF 250 RECIPIENTS OF CADAVERIC KIDNEY ALLOGRAFTS FROM DONORS OLDER THAN 55 YEARS OF AGE (VOL 27, PG 981, 1995)
    OPPENHEIMER, F
    CAMPISTOL, JM
    VILARDELL, J
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (02) : 1916 - 1916
  • [37] Donor Age >50 Years and CIT Longer Than 18 Hour Are Independent Risk Factors for One Year Graft Survival in Renal Transplant Form Uncontrolled Donors After Circulatory Death (uDCD)
    Molina, M.
    Gutierrez, E.
    Gonzalez, E.
    Morales, E.
    Cabrera, J.
    Andres, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 625 - 625
  • [38] Cementless metal-on-metal hip arthroplasty in patients less than 50 years of age - Comparison with a matched control group using ceramic-on-polyethylene after a minimum 5-year follow-up
    Migaud, H
    Jobin, A
    Chantelot, C
    Giraud, F
    Laffargue, P
    Duquennoy, A
    JOURNAL OF ARTHROPLASTY, 2004, 19 (08): : 23 - 28
  • [39] Higher Weight and Weight Gain after 4 Years of Age Rather than Weight at Birth Are Associated with Adiposity, Markers of Glucose Metabolism, and Blood Pressure in 5-Year-Old Ethiopian Children
    Wibaek, Rasmus
    Girma, Tsinuel
    Admassu, Bitiya
    Abera, Mubarek
    Abdissa, Alemseged
    Geto, Zeleke
    Kaestel, Pernille
    Vistisen, Dorte
    Jorgensen, Marit E.
    Wells, Jonathan C. K.
    Michaelsen, Kim F.
    Friis, Henrik
    Andersen, Gregers S.
    JOURNAL OF NUTRITION, 2019, 149 (10): : 1785 - 1796
  • [40] IMPROVED SURVIVAL AT 2 AND 5 YEARS IN THE LMCE1 UNSELECTED GROUP OF 72 CHILDREN WITH STAGE-IV NEUROBLASTOMA OLDER THAN 1-YEAR-OF-AGE AT DIAGNOSIS - IS CURE POSSIBLE IN A SMALL SUBGROUP
    PHILIP, T
    ZUCKER, JM
    BERNARD, JL
    LUTZ, P
    BORDIGONI, P
    PLOUVIER, E
    ROBERT, A
    ROCHE, H
    SOUILLET, G
    BOUFFET, E
    MICHON, J
    LOPEZ, M
    VILCOQ, JM
    GENTET, JC
    PHILIP, I
    LADENSTEIN, R
    FAVROT, M
    CHAUVIN, F
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) : 1037 - 1044